COMPANY PROFILE

Shanghai Huaotai Biopharmaceutical

Explore full profile

Biopharmaceutical company advancing a diverse pipeline of nonclinical and pre-IND therapeutic candidates

Huangpu, ChinaFounded 2013Biotech & Life Sciences

Valuation $250–500M Last recorded · 2026

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Shanghai Huaotai Biopharmaceutical

Huaota is a biopharmaceutical company focused on the research and development of therapeutic candidates. The company operates in the healthcare sector, specifically targeting unmet medical needs through its innovative drug pipeline. Huaota's business model revolves around advancing its diverse portfolio of nonclinical and pre-IND (Investigational New Drug) candidates, which include various biologics and small molecules aimed at treating a range of diseases. The company generates revenue through partnerships, licensing agreements, and potential future commercialization of its drug candidates. Huaota serves clients in the pharmaceutical and healthcare industries, collaborating with research institutions and other biotech firms to bring its products to market. The company's strategic focus on intellectual property and its robust product pipeline positions it as a key player in the biopharmaceutical landscape.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2013
Headquarters: Huangpu, China
Open positions: None listed
Dealroom signal: 20.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Dec 2024	$28M	$440M	Undisclosed	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Huaotai Biopharmaceutical website traffic

Latest recorded traffic for Shanghai Huaotai Biopharmaceutical is 720 monthly website visits, up 4.3% over the last three months.

Latest monthly visits720 3-month web change+4.3%

Monthly website visitsJan 2021–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
FMFocal MedicalApplying our sophisticated technology platforms to revolutionize the way drugs are delivered to improve patient healthcare outcomes	Cary, United States	Acquired	4	$12M	—
TWTwisterbiotechGene therapies for cancers and autoimmune diseases	Houston, United States	Operational
CTCV6 TherapeuticsCombination therapies enhancing cornerstone cancer and inflammatory treatments	Belfast, United Kingdom	Operational
ABAelius BiotechContract research company specialising in modelling the aero-digestive tract without the use of animal testing	Newcastle upon Tyne, United Kingdom	Operational
LBLeucid BioNext-generation CAR-T cell therapies for refractory cancers	London, United Kingdom	Operational
VBViaNautis BioPolymer nanoparticle platform for targeted intracellular genetic delivery	Cambridge, United Kingdom	Operational
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
RBRosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology	Bristol, United Kingdom	Operational

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

🇨🇳 China · Huangpu HQ

Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Huaotai Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Huaotai Biopharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.